Sfoglia per Autore
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate
1990-01-01 Perosa, F; Carbone, R.; Ferrone, S.; Dammacco, F.
Ibridizzazione in situ non isotopica. Attualità e prospettive
1992-01-01 Sansonno, D; Rizzi, R; Dammacco, F
Soluble CD4 and commercial immunoglobulins
1994-01-01 Perosa, Federico; Rizzi, Rita; Dammacco, Francesco
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab
1994-01-01 Perosa, F; Rizzi, R; Pulpito, V; Dammacco, F
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype
1999-01-01 Perosa, Federico; Prete, Marcella; Luccarelli, G; Favoino, B; Ferrone, S; Dammacco, F.
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression
2002-01-01 Perosa, F.; Prete, M.; Luccarelli, G.; Favoino, B.; Dammacco, F.
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide
2003-01-01 Perosa, F.; Luccarelli, G.; Prete, M.; Favoino, E.; Ferrone, S.; Dammacco, F.
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides
2007-01-01 Perosa, Federico; Favoino, E; Merchionne, Francesca; Dammacco, F.
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count
2009-01-01 Perosa, Federico; Minoia, C.; Favoino, Elvira; Prete, Marcella; Dammacco, F.
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab.
2010-01-01 Perosa, Federico; Musaraij, G; Racanelli, Vito; Favoino, Elvira; Dammacco, Francesco
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
2010-01-01 Dammacco, F; Tucci, Fa; Lauletta, G; Gatti, P; DE RE, V; Conteduca, V; Sansonno, S; Russi, S; Mariggio', M. A.; Chironna, M; Sansonno, D
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic
2010-01-01 Perosa, Federico; Prete, Marcella; Racanelli, Vito; Dammacco, Francesco
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies (Ab) and identifies a subset of anti-CENP Ab positive systemic sclerosis patients.
2010-01-01 Perosa, Federico; Vicenti, Chiara; Racanelli, Vito; Cuomo, G; Valentini, G; Dammacco, Francesco
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia.
2010-01-01 Racanelli, Vito; Leone, Patrizia; Brunetti, Claudia; Dicarlo, Manuela; De Re, V; Perosa, Federico; Dammacco, Francesco
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance
2010-01-01 Prete, Marcella; Perosa, Federico; Dammacco, Francesco
Autoantibodies to intracellular antigens: generation and pathogenetic role
2011-01-01 Racanelli, Vito; Prete, Marcella; Musaraj, Gerta; Dammacco, Francesco; Perosa, Federico
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets
2012-01-01 Berardi, S.; Caivano, A.; Ria, R.; Nico, B.; Savino, R.; Terracciano, R.; De Tullio, G.; Ferrucci, A.; De Luisi, A.; Moschetta, M.; Mangialardi, G.; Catacchio, I.; Basile, A.; Guarini, A.; Zito, A.; Ditonno, P.; Musto, P.; Dammacco, F.; Ribatti, D.; Vacca, A.
Goodpasture's disease: a report of ten cases and a review of the literature.
2013-01-01 Dammacco, Francesco; Battaglia, Stefano; Gesualdo, Loreto; Racanelli, Vito
Cancrini, Caterina, et al. "Clinical features and follow-up in patients with 22q11. 2 deletion syndrome." The Journal of pediatrics 164.6 (2014): 1475-1480.
2014-01-01 Cancrini, C; Puliafito, P; Digilio, Mc; Soresina, A; Martino, S; Rondelli, R; et al., Collaborators Pierani P; Gabrielli, A; Danieli, Mg; De Mattia, D; Sisto, C; Dammacco, F; Ranieri, G; Et, Al.
Dendritic cells are recruited to the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T cell killing.
2015-01-01 Leone, Patrizia; Berardi, Simona; Frassanito, Ma; Ria, Roberto; De Re, V; Cicco, Sebastiano; Battaglia, Stefano; Di Tonno, P; Dammacco, Francesco; Racanelli, Vito; Vacca, Angelo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile